1999 Vol.17, N°6 - Suppl.18 - Table of contents

Combination disease-modifying anti-rheumatic drug therapy in rheumatoid arthritis

Guest Editors: T. Pincus, F.C. Breedveld, P. Emery

Full Papers

CER1913
1999,17,6,Suppl.18
Pg. 0002-0007

Free to view

Does partial control of inflammation prevent long-term joint damage? Clinical rationale for combination therapy with multiple disease-modifying antirheumatic drugs
T. Pincus, F.C. Breedveld, P. Emery

CER1914
1999,17,6,Suppl.18
Pg. 0008-0012

Free to view

Early developments in combination therapy
D.L. Scott, S. Farrow, S.I. Yeo

CER1915
1999,17,6,Suppl.18
Pg. 0013-0019

Free to view

Pyramids to myriads: The combination conundrum in rheumatoid arthritis
D. O`Gradaigh, D.G.I. Scott

CER1916
1999,17,6,Suppl.18
Pg. 0020-0028

Free to view

Mechanisms of action of second-line agents and choice of drugs in combination therapy
E. Choy, G. Panayi

CER1917
1999,17,6,Suppl.18
Pg. 0029-0036

Free to view

Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (dmard) combinations to treat rheumatoid arthritis (RA)
T. Münster, D.E. Furst

CER1918
1999,17,6,Suppl.18
Pg. 0037-0042

Free to view

New approaches to imaging of early rheumatoid arthritis
P.G. Conaghan, D. McGonagle, R. Wakefield, P. Emery

CER1919
1999,17,6,Suppl.18
Pg. 0043-0046

Free to view

Methotrexate and emerging therapies
J.M. Kremer

CER1920
1999,17,6,Suppl.18
Pg. 0047-0052

Free to view

Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate
C.M. Stein, T. Pincus

CER1921
1999,17,6,Suppl.18
Pg. 0053-0058

Free to view

Combination DMARD therapy with hydroxychloroquine, sulfasalzine, and methotrexate
J.R. O

CER1922
1999,17,6,Suppl.18
Pg. 0059-0065

Free to view

Combination DMARD therapy including corticosteroids in early rheumatoid arthritis
T.T. Möttönen, P.J. Hannonen, M. Boers

CER1923
1999,17,6,Suppl.18
Pg. 0066-0068

Free to view

Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis
P.J. Mroczkowski, M.E. Weinblatt, J.M. Kremer

CER1924
1999,17,6,Suppl.18
Pg. 0069-0072

Free to view

Etanercept and methotrexate combination therapy
A.D. Bankhurst

CER1925
1999,17,6,Suppl.18
Pg. 0073-0077

Free to view

Combination therapy of the chimeric monoclonal anti-tumor necrosis factor α antibody (infliximab) with methotrexate in patients with rheumatoid arthritis
C. Antoni, J.R. Kalden

CER1926
1999,17,6,Suppl.18
Pg. 0078-0082

Free to view

Use of combination therapy in the routine care of patients with rheumatoid arthritis: Physician and patient surveys
D.J. Hawley, F. Wolfe, T. Pincus

CER1927
1999,17,6,Suppl.18
Pg. 0083-0090

Free to view

Combination DMARD treatment with parenteral gold and methotrexate
R. Rau

CER1928
1999,17,6,Suppl.18
Pg. 0091-0094

Free to view

Clinical experience with combination disease-modifying antirheumatic drug therapy with cyclosporine
K. Johns, G. Littlejohn

CER1929
1999,17,6,Suppl.18
Pg. 0095-0101

Free to view

Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine
Wm. Bensen, W. Bensen

CER1930
1999,17,6,Suppl.18
Pg. 0103-0104

Free to view

Combination cyclosporine and (hydroxy)chloroquine in rheumatoid arthritis
B.A.C. Dijkmans, R.B.M. Landewé, B.E.E.M. van den Borne, F.C. Breedveld

CER1931
1999,17,6,Suppl.18
Pg. 0105-0114

Free to view

TNFα and IL-1β are separate targets in chronic arthritis
W.B. van den Berg, L.A.B. Joosten, F.A.J. van de Loo

CER1932
1999,17,6,Suppl.18
Pg. 0115-0120

Free to view

Combination therapy with DMARDs and biological agents in collagen-induced arthritis
R.O. Williams, A.-M. Malfait, D.M. Butler, M.J. Walmsley, M. Feldmann, R.N. Maini

CER1933
1999,17,6,Suppl.18
Pg. 0121-0124

Free to view

Combination biologic therapy
J.D. Isaacs, A.W. Morgan, V. Strand